Ryman Healthcare Limited has announced plans to undertake a fully underwritten pro-rata 1 for 2.81 accelerated entitlement offer with retail entitlement trading on the NZX Main Board of new fully paid ordinary shares to eligible shareholders in New Zealand, Australia and other selected jurisdictions, with any shares not taken up or attributable to ineligible shareholders being offered to institutional investors through two shortfall bookbuild processes.
The offer, which is expected to raise NZ$902 million, is being made in reliance upon an exclusion in clause 19 of Schedule 1 to the Financial Markets Conduct Act 2013 and under the Australian Securities and Investments Commission Instrument 2015/356.
See more
